Achieving high quality anticoagulation management with specialised clinic care

1 Schulman, S. (2012). Is the warfarin saga over? J R Coll Physicians Edinb 42, 51-55. 2 Ryan, F., Byrne, S., & O’Shea, S. (2008). Managing oral anticoagulation therapy: improving clinical outcomes. A review. J Clin Pharm Ther 33, 581-590. 3 Eikelboom, J.W., & Hart, R.G. (2012). Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves. Am J Hematol 87, S100-S107. 4 Hart, R.G., Pearce, L.A., & Aguilar, M.I. (2007). Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146, 857-867. 5 Levi, M., de Peuter, O.R., & Kamphuisen, P.W. (2009). Management strategies for optimal control of anticoagulation in patients with atrial fibrillation. Semin Thromb Hemost 35, 560-567. 6 Garcia, D.A., Witt, D.M., Hylek, E., Wittkowsky, A.K., Nutescu, E.A. et al. (2008). Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum. Ann Pharmacother 42, 979-988. 7 D’Arcy, J.L., Prendergast, B.D., Chambers, J.B., Ray, S.G., & Bridgewater, B. (2011). Valvular heart disease: the next cardiac epidemic. Heart 97, 91-93. 8 Colilla, S., Crow, A., Petkun, W., Singer, D.E., Simon, T. et al. (2013). Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population. Am J Cardiol 112, 1142-1147. 9 Krijthe, B.P., Kunst, A., Benjamin, E.J., Lip, G.Y., Franco, O.H. et al. (2013). Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J 34, 2746-2751. 10 Fustinoni, O. (2011). The case for an elderly targeted stroke management. Front Neurol 2, 1-6. 11 Ma, C. (2012). Current antithrombotic treatment in East Asia: Some perspectives on anticoagulation and antiplatelet therapy. Thromb Haemost 107, 1014-1018. 12 Levi, M., Hobbs, F.D., Jacobson, A.K., Pisters, R., Prisco, D. et al. (2009). Improving antithrombotic management in patients with atrial fibrillation: current status and perspectives. Semin Thromb Hemost 35, 527-542. 13 Costa, G.L., Ferreira, D.C., Valacio, R.A., & Vieira Moreira, Mda C. (2011). Quality of management of oral anticoagulation as assessed by time in therapeutic INR range in elderly and younger patients with low mean years of formal education: a prospective cohort study. Age Ageing 40, 375-381. 14 Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M. et al. (2008). Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133, 160S-198S. 15 Wurster, M., & Doran, T. (2006). Anticoagulation management: a new approach. Dis Manag 9, 201-209. 16 Nichol, M.B., Knight, T.K., Dow, T., Wygant, G., Borok, G. et al. (2008). Quality of anticoagulation monitoring in nonvalvular atrial fibrillation patients: comparison of anticoagulation clinic versus usual care. Ann Pharmacother 42, 62-70. 17 Young, S., Bishop, L., Twells, L., Dillon, C., Hawboldt, J. et al. (2011). Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic. BMC Fam Pract 12, 1-7. 18 Saokaew, S., Sapoo, U., Nathisuwan, S., Chaiyakunapruk, N., & Permsuwan, U. (2012). Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand. Int J Clin Pharm 34, 105-112. 19 Nasser, S., Mullan, J., & Bajorek, B. (2011). Challenges of older patients’ knowledge about warfarin therapy. J Prim Care & Comm Health, 1-10. 20 Ebell, M.H. (2005). A systematic approach to managing warfarin doses. Fam Pract Manag 12, 77-83. 21 Rudd, K.M., & Dier, J.G. (2010). Comparison of two different models of anticoagulation management services with usual medical care. Pharmacotherapy 30, 330-338. 22 Bloomfield, H.E., Krause, A., Greer, N., Taylor, B.C., MacDonald, R. et al. (2011). Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes. Ann Intern Med 154, 472-482. 23 Phillips, K.W., & Ansell, J. (2008). Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management. Exp Rev Cardiovasc Ther 6, 57-70. 24 Wan, Y., Heneghan, C., Perera, R., Roberts, N., Hollowell, J. et al. (2008). Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circ Cardiovasc Qual Outcomes 1, 84-91. 25 Ansell, J.E. (2003). Optimizing the efficacy and safety of oral anticoagulant therapy: high-quality dose management, anticoagulation clinics, and patient self-management. Semin Vasc Med 3, 261-270. 26 Chamberlain, M.A., Sageser, N.A., & Ruiz, D. (2001). Comparison of anticoagulation clinic patient outcomes with outcomes from traditional care in a family medicine clinic. J Am Board Fam Pract 14, 16-21. 27 Witt, D.M. (2010). Optimizing use of current anticoagulants. Hematol Oncol Clin North Am 24, 717-726. 28 Chan, F.W., Wong, R.S., Lau, W.H., Chan, T.Y., Cheng, G. et al. (2006). Management of Chinese patients on warfarin therapy in two models of anticoagulation service – a prospective randomized trial. Br J Clin Pharmacol 62, 601-609. 29 Garton, L., & Crosby, J.F. (2011). A retrospective assessment comparing pharmacist-managed anticoagulation clinic with physician management using international normalized ratio stability. J Thromb Thrombolysis 32, 426-430. 30 Wittkowsky, A.K., Nutescu, E.A., Blackburn, J., Mullins, J., Hardman, J. et al. (2006). Outcomes of oral anticoagulant therapy managed by telephone vs in-office visits in an anticoagulation clinic setting. Chest 130, 1385-1389. 31 Setting the standards in anticoagulation service delivery. Educational resource produced by Anticoagulation Europe, the National Centre for Anticoagulation Training (NCAT) and Roche Diagnostics in 2006. Available at http://www.roche.co.uk/fmfiles/re7208002/ products_services/anticoagulationCare/Setting_the_Standards_in_Anticoagulation_ Service_ Delivery.pdf (last accessed January 2014). 32 Woods, K., Douketis, J.D., Schnurr, T., Kinnon, K., Powers, P. et al. (2004). Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial. Thromb Res 114, 161-165. 33 Bungard, T.J., Ritchie, B., Garg, S., & Tsuyuki, R.T. (2012). Sustained impact of anticoagulant control achieved in an anticoagulation management service after transfer of management to the primary care physician. Pharmacotherapy 32, 112-119. 34 Wilson, S.J., Wells, P.S., Kovacs, M.J., Lewis, G.M., Martin, J. et al. (2003). Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. CMAJ 169, 293-298. “I know my value”